Log in to save to my catalogue

Exagamglogene Autotemcel for Transfusion-Dependent β-Thalassemia

Exagamglogene Autotemcel for Transfusion-Dependent β-Thalassemia

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_3046516229

Exagamglogene Autotemcel for Transfusion-Dependent β-Thalassemia

About this item

Publication information

Publisher

United States: Massachusetts Medical Society

More information

Scope and Contents

Contents

Of 35 patients with transfusion-dependent β-thalassemia treated with gene-edited autologous hematopoietic stem and progenitor cells, 32 had hemoglobin levels maintained without red-cell transfusions for at least 12 consecutive months.

Alternative Titles

Full title

Exagamglogene Autotemcel for Transfusion-Dependent β-Thalassemia

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_miscellaneous_3046516229

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_3046516229

Other Identifiers

ISSN

0028-4793,1533-4406

E-ISSN

1533-4406

DOI

10.1056/NEJMoa2309673

How to access this item